Patents by Inventor CATERINA LO PRESTI

CATERINA LO PRESTI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FGF-18 formulation in xyloglucan gels
    Patent number: 10293051
    Abstract: The invention relates to the field of pharmaceutical formulations. More particularly, it is directed to xyloglucan hydrogels comprising Fibroblast Growth Factor 18 (FGF-18) compounds and methods of producing such hydrogels. The hydrogels of the invention can be used, once formed in situ, for the treatment of cartilage disorders such as osteoarthritis or cartilage injury.
    Type: Grant
    Filed: December 23, 2014
    Date of Patent: May 21, 2019
    Assignee: ARES TRADING S.A.
    Inventors: Caterina Lo Presti, Donatella Bulone, Clelia Dispenza
  • FGF-18 formulation in alginate/collagen hydrogels
    Patent number: 9795714
    Abstract: The invention relates to the field of pharmaceutical formulations. More particularly, it is directed to homogeneous hydrogels comprising Fibroblast Growth Factor 18 (FGF-18) compound and to methods of producing such hydrogels. The hydrogels of the invention can be used, once formed in situ, for the treatment of cartilage disorders such as osteoarthritis or cartilage injury.
    Type: Grant
    Filed: December 23, 2014
    Date of Patent: October 24, 2017
    Assignee: ARES TRADING S.A.
    Inventors: Fabiana Canal, Caterina Lo Presti
  • FGF-18 FORMULATION IN XYLOGLUCAN GELS
    Publication number: 20160317668
    Abstract: The invention relates to the field of pharmaceutical formulations. More particularly it is directed to xyloglucan hydrogels comprising Fibroblast Growth Factor 18 (FGF-18) compound and to methods of producing such hydrogels. The hydrogels of the invention can be used, once formed in situ, for the treatment of cartilage disorders such as osteoarthritis or cartilage injury.
    Type: Application
    Filed: December 23, 2014
    Publication date: November 3, 2016
    Applicant: ARES Trading S.A.
    Inventors: CATERINA LO PRESTI, DONATELLA BULONE, CLELIA DISPENZA
  • FGF-18 FORMULATION IN ALGINATE/COLLAGEN HYDROGELS
    Publication number: 20160303291
    Abstract: The invention relates to the field of pharmaceutical formulations. More particularly it is directed to homogeneous hydrogels comprising Fibroblast Growth Factor 18 (FGF-18) compound and to methods of producing such hydrogels. The hydrogels of the invention can be used, once formed in situ, for the treatment of cartilage disorders such as osteoarthritis or cartilage injury.
    Type: Application
    Filed: December 23, 2014
    Publication date: October 20, 2016
    Inventors: FABIANA CANAL, CATERINA LO PRESTI